Compare Stocks

→ Your Next Portfolio Star: Revealing 2024's Top Stock Pick (From Darwin) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ALSSF Alsea	$4.35	$4.25	$2.35 ▼ $4.95	N/A	N/A	13,982 shs	N/A
BPZZF Boston Pizza Royalties Income Fund	$11.45 +0.1%	$11.53	$10.50 ▼ $12.80	N/A	N/A	931 shs	4,737 shs
CARA Cara Therapeutics	$0.69 -0.7%	$0.82	$0.50 ▼ $4.67	$37.44M	0.7	661,546 shs	205,638 shs
WTBDY Whitbread	$9.53 -0.2%	$10.39	$9.52 ▼ $11.91	N/A	N/A	8,892 shs	7,105 shs

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ALSSF Alsea	0.00%	+1.16%	+1.40%	+14.47%	+67.31%
BPZZF Boston Pizza Royalties Income Fund	+0.12%	-1.55%	-1.22%	+0.17%	-2.97%
CARA Cara Therapeutics	-5.72%	-14.88%	-22.47%	+22.12%	-83.57%
WTBDY Whitbread	-0.21%	-4.32%	-5.78%	-15.54%	-3.35%

Special FREE offer on stock hotsheets (Ad)

These sheets tell you the exact day you should consider buying a stock… And the exact day you should consider selling it… All based on TEN YEARS of historic data and trends. For example, like January 6th through the 12th with Apple… It’s gone up every single year for the last decade. Or like May 26th through June 11th with LULU… Again - it’s gone up every single year for the last decade. Then there’s July 1st through the 21st with Walmart… What happened to WMT?

Click here and I’ll show you

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ALSSF Alsea	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
BPZZF Boston Pizza Royalties Income Fund	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
CARA Cara Therapeutics	3.9163 of 5 stars	3.4	2.0	0.0	4.2	2.0	1.7	1.3
WTBDY Whitbread	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ALSSF Alsea	N/A	N/A	N/A	N/A
BPZZF Boston Pizza Royalties Income Fund	N/A	N/A	N/A	N/A
CARA Cara Therapeutics	2.75	Moderate Buy	$9.75	1,323.36% Upside
WTBDY Whitbread	N/A	N/A	N/A	N/A

Current Analyst Ratings

Latest WTBDY, ALSSF, BPZZF, and CARA Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/10/2024	CARA Cara Therapeutics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$5.00
3/28/2024	CARA Cara Therapeutics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$5.00
3/6/2024	CARA Cara Therapeutics	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$11.00 ➝ $10.00
3/5/2024	CARA Cara Therapeutics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$5.00
1/22/2024	CARA Cara Therapeutics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$6.00 ➝ $5.00

(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ALSSF Alsea	N/A	N/A	N/A	N/A	N/A	N/A
BPZZF Boston Pizza Royalties Income Fund	N/A	N/A	N/A	N/A	N/A	N/A
CARA Cara Therapeutics	$20.97M	1.79	N/A	N/A	$1.05 per share	0.65
WTBDY Whitbread	N/A	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ALSSF Alsea	N/A	$1.06	4.10	∞	N/A	N/A	N/A	N/A	N/A
BPZZF Boston Pizza Royalties Income Fund	N/A	$1.26	9.12	∞	N/A	N/A	N/A	N/A	5/8/2024 (Estimated)
CARA Cara Therapeutics	-$118.51M	-$2.18	N/A	N/A	N/A	-565.21%	-122.10%	-89.64%	5/20/2024 (Estimated)
WTBDY Whitbread	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A

Latest WTBDY, ALSSF, BPZZF, and CARA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
3/4/2024	12/31/2023	CARA Cara Therapeutics	-$0.57	-$0.59	-$0.02	-$0.59	$2.34 million	$3.00 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ALSSF Alsea	N/A	N/A	N/A	N/A	N/A
BPZZF Boston Pizza Royalties Income Fund	$0.82	7.13%	N/A	65.00%	N/A
CARA Cara Therapeutics	N/A	N/A	N/A	N/A	N/A
WTBDY Whitbread	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ALSSF Alsea	N/A	N/A	N/A
BPZZF Boston Pizza Royalties Income Fund	N/A	N/A	N/A
CARA Cara Therapeutics	N/A	4.54	4.43
WTBDY Whitbread	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
ALSSF Alsea	22.50%
BPZZF Boston Pizza Royalties Income Fund	25.97%
CARA Cara Therapeutics	44.66%
WTBDY Whitbread	N/A

Insider Ownership

Company	Insider Ownership
ALSSF Alsea	N/A
BPZZF Boston Pizza Royalties Income Fund	N/A
CARA Cara Therapeutics	4.20%
WTBDY Whitbread	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
ALSSF Alsea	79,271	N/A	N/A	Not Optionable
BPZZF Boston Pizza Royalties Income Fund	N/A	N/A	N/A	Not Optionable
CARA Cara Therapeutics	55	54.66 million	52.36 million	Optionable
WTBDY Whitbread	39,000	N/A	N/A	Not Optionable

WTBDY, ALSSF, BPZZF, and CARA Headlines

Source	Headline
	Whitbread (OTCMKTS:WTBDY) Shares Down 0.2% americanbankingnews.com - April 19 at 2:20 AM
	Opinion: European companies are finally buying back their stock, opening up opportunities msn.com - April 10 at 9:30 PM
	Whitbread has plenty of upside, says American investment bank proactiveinvestors.com - March 19 at 11:20 AM
	Premier Inn owner Whitbread's headwinds priced in - analyst proactiveinvestors.co.uk - March 5 at 11:07 AM
	Whitbread PLC ADR WTBDY morningstar.com - February 25 at 11:55 PM
	With 85% institutional ownership, Whitbread plc (LON:WTB) is a favorite amongst the big guns finance.yahoo.com - February 13 at 3:31 AM
	Jefferies bullish on Whitbread following strong UK data realmoney.thestreet.com - December 19 at 7:36 AM
	Whitbread goes ex-dividend tomorrow msn.com - November 1 at 4:00 PM
	With EPS Growth And More, Whitbread (LON:WTB) Makes An Interesting Case finance.yahoo.com - October 17 at 4:27 AM
	Hull KR confirm Jai Whitbread capture with Rovers' 2024 quota spots filled hulldailymail.co.uk - October 14 at 10:13 AM
	Whitbread prize favourites dailymail.co.uk - October 8 at 8:16 AM
	Is It Time To Consider Buying Whitbread plc (LON:WTB)? finance.yahoo.com - September 26 at 1:00 PM
	WTBDY - Whitbread plc finance.yahoo.com - September 22 at 7:31 AM
	WTB.L - Whitbread plc finance.yahoo.com - July 28 at 3:44 PM
	Whitbread Full Year 2023 Earnings: EPS: UK£1.38 (vs UK£0.21 in FY 2022) finance.yahoo.com - May 30 at 2:36 AM
	Whitbread-owned Premier Inn is looking to add to its portfolio of Dublin hotels as revenues jump independent.ie - January 16 at 2:16 AM
	Fatima Whitbread branded Celebrity SAS: Who Dares Wins 'legend' as she shares heartbreaking past chroniclelive.co.uk - September 12 at 2:39 AM
	Whitbread plc Ordinary 76 122/153p Shares hl.co.uk - September 9 at 4:10 AM
	Whitbread bbc.com - September 9 at 4:10 AM
	Whitbread plc ADR News thestreet.com - July 17 at 11:57 PM
	Here is how city analysts rate Whitbread uk.finance.yahoo.com - June 10 at 9:43 AM
	Whitbread plc 2022 Q1 - Results - Earnings Call Presentation seekingalpha.com - April 30 at 11:56 PM
	Premier Inn’s Owner Whitbread Is Finding Shelter From Inflation Pressures finance.yahoo.com - April 29 at 8:35 PM
	Premier Inn owner Whitbread says its UK business resilient amid Omicron spread ca.finance.yahoo.com - January 13 at 10:42 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Alsea

OTCMKTS:ALSSF

Alsea, S.A.B. de C.V. operates restaurants in Latin America and Europe. It operates fast food, coffee shops, casual food, and family restaurants under the Domino's Pizza, Starbucks, Burger King, Chili's, PF Chang's, Italianni's, The Cheesecake Factory, Vips, The gate, Foster's Hollywood, Archies, Ginos, T.G.I. Fridays, Vips Europe, Vips Smart, Ole Mole, and Clay Hear brands. The company was incorporated in 1997 and is headquartered in Mexico City, Mexico.

Boston Pizza Royalties Income Fund

OTCMKTS:BPZZF

Boston Pizza Royalties Income Fund operates as a limited purpose open-ended trust. The company, indirectly through Boston Pizza Royalties Limited Partnership, owns trade-marks used by Boston Pizza International Inc. It operates and franchises Boston Pizza restaurants. The company was founded in 1964 and is based in Richmond, Canada. Boston Pizza Royalties Income Fund operates as a subsidiary of James Treliving Holdings Ltd.

Cara Therapeutics

NASDAQ:CARA

Cara Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing therapeutics treatment of chronic pruritus in the United States. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD) in adults undergoing hemodialysis. It also develops Oral difelikefalin, which is in Phase II/III clinical trial to treat chronic pruritus with notalgia paresthetica. The company has license agreements with Maruishi Pharmaceutical Co., Ltd to develop, manufacture, and commercialize drug products containing difelikefalin for acute pain and uremic pruritus in Japan; Vifor Fresenius Medical Care Renal Pharma Ltd. development and commercialization of KORSUVA injection for the treatment of moderate-to-severe pruritus in adult patients undergoing hemodialysis; and Chong Kun Dang Pharmaceutical Corporation to develop, manufacture, and commercialize drug products containing difelikefalin in South Korea. Cara Therapeutics, Inc. was incorporated in 2004 and is based in Stamford, Connecticut.

Whitbread

OTCMKTS:WTBDY

Whitbread plc operates hotels and restaurants in the United Kingdom, Germany, and internationally. It operates hotels with rooms in the United Kingdom; Middle East; and Germany under the Premier Inn, ZIP by Premier Inn, and hub by Premier Inn brands. The company operates restaurants under the Brewers Fayre, Beefeater, Cookhouse & Pub, Bar+Block Steakhouse, Thyme, and Table Table brands in the United Kingdom. Whitbread plc was founded in 1742 and is headquartered in Dunstable, the United Kingdom.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial